Akebia Therapeutics Inc. buy Lokrim
Start price
18.03.24
/
20%
€1.73
Target price
18.03.25
-
Performance (%)
-27.86%
Price
26.04.24
€1.25
Summary
This prediction is currently active. The prediction for Akebia Therapeutics Inc. disappoints with a performance of -27.86%. This prediction currently runs until 18.03.25. The prediction end date can be changed by Lokrim at any time. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Akebia Therapeutics Inc. | -1.887% | -1.887% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
According to Lokrim what are the pros and cons of Akebia Therapeutics Inc. for the foreseeable future?
Pros
Medium risks for its business
Cons
Comments by Lokrim for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Buy Akebia Therapeutics Inc.